Gilead Sciences, Inc. GILD
Set alert
170.33 USD -0.35 -0.21%
At close
170.98 +0.65 +0.38%
Pre-market · Nov 3, 7:34 AM ET
166.38 Day range 172.61
116.88 52-week range 175.65
- YTD
- +38.77%
- 1 year
- +39.56%
- Open
- 169.85
- Prev close
- 170.68
- Mkt cap
- 211.27B
- Vol
- 8.88M
- Avg vol
- 6.14M
- EPS
- -3.13
- P/E
- 0.00
- Div yield
- 1.98%
More statistics
- Low
- 166.38
- High
- 172.61
- Forward P/E
- 16.88
- Beta
- 0.37
- Short ratio
- 3.40
- Inst. own
- 92.01%
- Dividend
- 3.28
- Ex-div date
- Dec 14, 2026
- Earnings
- Feb 9, 2027
- 50-d avg
- 150.87
- 200-d avg
- 139.88
- 1y target
- 172.50
3M chart
Events in this range
- Aug 3, 2026Earnings: -6.75; estimate -7.25; surprise 6.9%
- Sep 15, 2026Dividend: 0.82
- Oct 29, 2026Earnings: 2.55; estimate 2.19; surprise 16.44%
- Oct 30, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 30, 2026Rating: TD Cowen · Buy → Buy
- Oct 30, 2026Rating: Scotiabank · Sector Outperform → Sector Outperform
- Oct 30, 2026Rating: Citigroup · Buy → Buy
- Oct 30, 2026Rating: JP Morgan · Overweight → Overweight
- Oct 30, 2026Rating: UBS · Buy → Buy
Signals (13)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 5, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 172.50 +1.3% upside
Now 170.33
- Target (low)
- 131.00
- Target (mean)
- 172.50
- Target (high)
- 200.00
Ratings (0m) 28 22 buy · 5 hold · 1 sell
- Strong buy6
- Buy16
- Hold5
- Sell0
- Strong sell1
Recommendation trend
- This month 28
- 1 month ago 28
- 2 months ago 29
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.07 | 0.02175 – 1.27 | 1.86 | -42.5% | 8.31B | +4.9% | 17 |
| Next quarter | 2.17 | 1.90 – 2.38 | 2.03 | +7.1% | 7.47B | +7.3% | 7 |
| Current year | -0.98893 | -1.20 – -0.73 | 8.15 | -112.1% | 31.29B | +6.3% | 20 |
| Next year | 10.09 | 8.91 – 12.41 | -0.98893 | +1120.5% | 33.55B | +7.2% | 26 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | UBS | Maintained | Buy | Buy |
| Oct 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 30, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Oct 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 30, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 30, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 30, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Needham | Maintained | Buy | Buy |
| Oct 20, 2026 | B of A Securities | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 8, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 7, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 10, 2026 | HSBC | Maintained | Buy | Buy |
| Aug 5, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Aug 5, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 5, 2026 | Needham | Reiterated | Buy | Buy |
| Jul 29, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 27, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 21, 2026 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Jul 8, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 7, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 6, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jul 6, 2026 | HSBC | Upgrade | Hold | Buy |
| Jun 16, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |